Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity
US12286401B2 · kind B2 · utility
0Cited by
3References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 31, 2019 |
| Grant date | Apr 29, 2025 |
| Priority date | — |
| Expiry date | Jul 31, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds and methods of treating HIV-1 in a human infected with HIV-1 or preventing HIV-1 infection in a human susceptible to infection with HIV-1 are provided. The compounds are of formula (I), (II), and (IA), wherein R1-R7, X, X′, Y, Y′, Z, and n are defined herein, and the methods comprises administering therapeutically effective amounts of these compounds to the human.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.